Thanks to a $4.3 million award, CvilleBioHub is building out a laboratory accelerator providing resources to up-and-coming ...

Stephens reiterated their equal weight rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research report report ...

Agnes Asagbra has emphasized the importance of safely utilizing modern biotechnology to promote environmental sustainability.

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “overweight” rating restated by equities research ...

The upcoming Biotech Act will be part of the measures the Commission will target to turbo-charge investment and efficiency in ...

The need to harness and tap into numerous benefits of Genetically Modified Organisms (GMOS) has become paramount in the prevailing food insecurity being witness in the country. However, the battle for ...

Inhibrx Biosciences , Inc. (NASDAQ:INBX), a clinical-stage biopharmaceutical company valued at $205.41 million, is navigating a critical phase in its development as it advances its oncology pipeline.

Turn your career aspirations into reality with this step-by-step guide to creating and implementing a strategic professional ...

Fidelity Advisor Biotechnology Fund earns an Above Average ... losses on some products in pursuit of broader strategic objectives. The firm is not without blemishes. Many of the active equity ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.

Sana Biotechnology, Inc SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today ...